This document provides updated laboratory medicine practice guidelines for the analytical evaluation and clinical implementation of cardiac biomarkers in acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Updates 1999 NACB standards for cardiac troponin; extends Level 1 recommendations for ACS evaluation.
MEMBERS et al. (2007) conducted a review in Acute Coronary Syndromes. Biochemical markers of acute coronary syndromes was evaluated. Updated practice guidelines provide evidence-based recommendations addressing analytical issues for cardiac biomarkers, including cardiac troponin, in acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: